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The anterior nares are the most important screening site of
colonization with Staphylococcus aureus. We screened 2966
individuals for S. aureus carriage with swabs of both nares
and throat. A total of 37.1% of persons were nasal carriers,
and 12.8% were solely throat carriers. Screening of throat
swabs significantly increases the sensitivity of detection
among carriers by 25.7%.
The anterior nares are considered to be the primary coloni-
zation site of Staphylococcus aureus [1–3]. Approximately 30%
of the healthy population carries S. aureus in their anterior
nares [4, 5]. Carriage of S. aureus in the nose appears to play
a key role in the epidemiology and pathogenesis of infection
and is associated with an increased risk of infectious compli-
cations after surgery in patients with end-stage renal failure and
in those with intravascular devices [1, 6]. Approximately 80%
of invasive nosocomial infections are of endogenous origin in
nasal carriers [7, 8].
The emergence of methicillin-resistant S. aureus (MRSA) in
hospitals and in the community has triggered many screening
programs to identify carriers of S. aureus—in particular, MRSA.
Early identification of carriers is a crucial step in MRSA pre-
vention programs; this is especially true for “search and de-
stroy” strategies, which are recommended in The Netherlands
[9]. Screening of all persons who are admitted to the hospital
is currently being debated in the United States.
Most S. aureus screening programs that include MRSA re-
quire obtainment of a swab specimen from the anterior nares
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only; a swab specimen from the throat is not yet considered
to be standard. The additional yield of culturing the throat is
considered to be negligible, because it adds discomfort for the
patient and cost to the health care system without significantly
increased sensitivity. This belief is based on the observation that
throat carriers of S. aureus are likely to carry S. aureus in the
nares as well. However, colonization of the throat but not of
the nares may be more common than is currently
acknowledged.
Publications from the 1940s reported throat colonization
rates of 4%–63% [3]. A recent study confirmed the observation
that the throat may be selectively colonized and escape current
routine screening programs [10].
Unrecognized carriers may spread MRSA and render infec-
tion-control programs futile. Therefore, we questioned the
practice of screening of the anterior nares alone and evaluated
the additional benefit of screening both the nares and the throat
in 4 different study populations.
Patients and methods. We collected data from 4 different
groups of individuals. The first group included patients and
health care workers who were screened after exposure to an
MRSA carrier during the years 2000–2005. Since 1997, this
procedure has been part of the hospital’s policy for prevention
of the spread of MRSA. The second group consisted of health
care workers who participated in a trade fair for medical and
hospital equipment (the Internationale Fachmesse fu¨r Arzt-
und Spitalbedorf convention at an exhibition center in Zurich,
Switzerland) on 26–29 October 2004 and who volunteered to
participate in a prevalence survey of S. aureus carriage among
the Swiss population. The third group included healthy blood
donors who were screened for S. aureus in the year 2005. Group
4 consists of a large sample of nasal and throat cultures that
were pooled in the laboratory; separate results are not available.
This group consists of patients and health care workers, as in
group 1.
MRSA carriers were analyzed separately to avoid any poten-
tial bias, because it is unknown whether MRSA has the same
colonization pattern as methicillin-susceptible S. aureus
(MSSA). Screening was performed by infection-control nurses
or physicians after appropriate training. The study was ap-
proved by the human subjects committee of the University of
Basel (Switzerland).
Specimens were obtained with a sterile polyester fiber–tipped
swab that had been moistened with sterile saline; samples were
taken from the anterior nares (5 rotations in each anterior
nostril) and from the posterior wall of the pharynx using a
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Table. 1. Rates of isolation of Staphylococcus aureus from the anterior nares and the throat.
Variable Groups 1–3 Group 1 Group 2 Group 3 Group 4
No. of persons screened 2966 832 634 1500 2075
No. with S. aureus carriage 1480 369 304 807 1082
Overall rate of positivity, % 49.9 44.4 47.9 53.8 52.1
Nares cultures
No. of persons with positive results 1100 301 237 562 …
Overall rate of positivity, % 37.1 36.2 37.4 37.5 …
Overall rate of positivity among carriers, % 74.3 81.5 77.9 69.6 …
Nares and throat cultures
Positive results of both
No. of persons 650 188 119 343 …
Overall rate of positivity among carriers, % 43.9 50.9 39.1 42.5 …
Positive results of nares cultures and
negative results of throat cultures
No. of persons 450 113 118 219 …
Overall rate of positivity among carriers, % 30.4 30.6 38.8 27.1 …
Negative results of nares cultures and
positive results of throat cultures
No. of persons 380 68 67 245 …
Overall rate of positivity, % 12.8 8.2 10.6 16.3 …
Overall rate of positivity among carriers, % 25.7 18.4 22.0 30.4 …
NOTE. Group 1, persons who underwent S. aureus screening during hospital stay; group 2, health care workers; group
3, blood donors; group 4, patients and health care workers for whom swabs from the nares and throat were pooled and for
whom separate results were unavailable.
second swab. Swabs were sent to the laboratory in a transport
tube (M40 Transystem; Copan) and were processed within 24
h. For culture, a selective enrichment broth (brain heart in-
fusion broth with 6% NaCl) was inoculated. After incubation
at 35C overnight, the broth was subcultured onto both chro-
mogenic agar for S. aureus (Chromagar Staph.aureus; Hy Lab-
oratories) and Columbia agar with 5% sheep blood (Becton
Dickinson). Plates were read after 24 and 48 h, and colonies
that were suspected of being S. aureus were further analyzed.
S. aureus was identified on the basis of various traits, such as
typical growth on the chromogenic medium and/or blood agar
and detection of clumping factor, protein A, and capsular an-
tigens (Pastorex Staph-Plus; Bio-Rad). S. aureus isolates were
tested for oxacillin resistance by using an oxacillin disk, an
oxacillin screening agar plate, or, more recently, a cefoxitin disk,
in accordance with guidelines issued by the Clinical and Lab-
oratory Standards Institute (formerly NCCLS). If results were
equivocal or if MRSA was suspected, additional tests were per-
formed, as follows: the presence of aurease was determined
using Rapidec staph (bioMe´rieux), the MRSA-Screen (Denka
Seiken) was used to detect penicillin-binding protein 2a, and
PCR was used to detect the mecA and femA genes; also, a
comprehensive antibiogram was performed in accordance with
the Clinical and Laboratory Standards Institute guidelines.
Results. A total of 5041 persons were included in our study.
Three groups (groups 1–3), which included a total of 2966
individuals, were screened for S. aureus carriage, with separate
results for nose and throat carriage. A fourth group (group 4)
consisted of 2075 individuals for whom data from nares and
throat swabs were pooled in the laboratory. The average age
was years, and 50.4% of the subjects were female. In50 21
groups 1–3, a total of 1480 individuals (49.9%) tested positive
for S. aureus (table 1). A total of 37.1% of the study population
(in groups 1–3) had nasal carriage of S. aureus, with or without
positive throat culture results. A total of 380 persons (12.8%
of the study population and 25.7% of the S. aureus carriers)
were colonized in the throat alone. Thus, screening of the throat
significantly increased the sensitivity by 25.7%. The anterior
nares were the site most frequently colonized with S. aureus,
with the exception of the group of blood donors; among blood
donors, the throat swab cultures yielded S. aureus more fre-
quently than cultures of swab specimens from the nares. The
rate of S. aureus carriage in group 4 (i.e., the pooled results
group) was 52.1%, which is similar to that observed with the
combined results for nares and throat swab cultures in groups
1–3.
A subset analysis was performed for 37 subjects with MRSA
carriage (0.74% of all individuals screened). In 23 MRSA car-
riers, separate results were available for cultures of throat and
nasal swab specimens. The additional yield of throat cultures
was comparable with the results described for MSSA: 5 of 23
(22% of all MRSA carriers versus 25.7% of all MSSA carriers).
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Discussion. To our knowledge, this is the largest study to
have evaluated the importance of the throat in S. aureus car-
riage. The additional throat swab cultures increased the yield
from 37% (cultures of nares swabs only) to almost 50% (cul-
tures of nares and throat swabs combined), an increase of sen-
sitivity by 25.7%. Results for group 4 (the pooled specimen
group)—separate cultures of swab specimens from nares and
the throat were not performed—corroborated the results for
groups 1–3, with a prevalence of S. aureus carriage of 49.9%
and 52.1%, respectively. Therefore, pooling culture results for
swabs from nares and the throat may be an appropriate method
to optimize the yield of S. aureus–positive while saving the
expenses of additional cultures.
Today, S. aureus screening is mainly performed to identify
MRSA carriers. Unidentified throat carriers may spread MRSA,
explaining, in part, why many decolonization schemes are
prone to failure. Throat carriage even triggered a large outbreak
of MRSA infection, which was traced back to a health care
worker who was solely colonized in the throat. Routine nasal
screening failed to identify this carrier [11]. Admission screen-
ing of selected patients or of all patients that aims to control
MRSA infection is performed in many hospitals, but screening
focuses on the nares along in most institutions [9]. However,
throat swab specimens have been obtained routinely in The
Netherlands for decades as part of the successful search-and-
destroy policy, which is outlined in their national guidelines
(http://www.wip.nl).
Our data confirm the results of previous studies that the
anterior nares are the single most colonized site with S. aureus.
The rate of carriage was higher in the throat than in the nares
only among blood donors (group 3). The finding may be related
to the fact that only 1 trained, highly motivated investigator
obtained all of these swab specimens. Untrained investigators
may find it difficult to screen the posterior wall of the throat
while avoiding patient discomfort. Alternatively, throat carriage
may indeed be more common among healthy individuals than
among individuals who are exposed to the health care system,
but such a hypothesis requires confirmation by other investi-
gators in different, non–health care populations.
Overall, the prevalence of carriage was ∼50%, which is higher
than the rate reported in most other studies (25%–35%) [5].
Several factors may explain this discrepancy. First, in other
studies, throat carriage was not taken into account. In fact, the
rate of nasal carriage (with data from throat cultures excluded)
was comparable at a rate of 37.1%. Second, enrichment broth
may have additionally increased the sensitivity of the culture
[12]. Third, only specially trained health care workers obtained
the swab specimens, so samples were obtained from posterior
wall of the throat and not the mouth.
The addition of throat cultures to cultures of swabs from
the anterior nares significantly increased the sensitivity of
screening by 25.7%. Overall, 37.1% of subjects had nasal car-
riage of S. aureus, but 12.8% of the individuals had throat
carriage alone, and these subjects would have escaped tradi-
tional screening methods. Therefore, any screening for S. au-
reus—in particular, screening for MRSA—should include both
cultures of swabs samples from the anterior nares and the
throat. Pooling the samples can maintain the additional ex-
penses associated with throat screening while maintaining
sensitivity.
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